Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A chronic, progressive lung disease characterized by inflammation and scarring (fibrosis) of the lung tissue, caused by an immune response to inhaled antigens.
Biomarker and diagnostic research for fibrotic hypersensitivity pneumonitis has been reported in the published literature.
2 clinical trials registered. Interventions under study include drug therapy. Pipeline includes 1 PHASE4, 1 PHASE3. Research is primarily sponsored by academic and government institutions.
81 publications have been identified in PubMed for fibrotic hypersensitivity pneumonitis. Research spans Epidemiology / Natural History (28%), Diagnostic / Biomarker (26%), and Case Report / Case Series (13%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 22 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:54 AM UTC
European rare disease database
Testing and diagnosis research | 20 | 26% |
Patient case studies | 10 | 13% |
Research summaries | 8 | 10% |
Clinical study results | 8 | 10% |
Laboratory research | 6 | 8% |
Other research | 2 | 3% |
New treatment approaches | 2 | 3% |
Marinescu DC (2026). [PMID: 41842670](https://pubmed.ncbi.nlm.nih.gov/41842670/). *Radiology*. [Clinical Trial Publication]
Sellers T (2026). [PMID: 41513513](https://pubmed.ncbi.nlm.nih.gov/41513513/). *Semin Roentgenol*. [Review / Meta-Analysis]
Kızıloğlu HA (2026). [PMID: 41998456](https://pubmed.ncbi.nlm.nih.gov/41998456/). *J Imaging Inform Med*. [Diagnostic / Biomarker]
Diesler R (2026). [PMID: 41887671](https://pubmed.ncbi.nlm.nih.gov/41887671/). *Eur Respir J*. [Diagnostic / Biomarker]
Konkol SB (2026). [PMID: 41802591](https://pubmed.ncbi.nlm.nih.gov/41802591/). *Chest*. [Basic Science / Preclinical]
Pilia MF (2026). [PMID: 41785213](https://pubmed.ncbi.nlm.nih.gov/41785213/). *Respiration*. [Epidemiology / Natural History]
Kaenmuang P (2026). [PMID: 41478152](https://pubmed.ncbi.nlm.nih.gov/41478152/). *Respir Investig*. [Basic Science / Preclinical]
Giacomo J (2026). [PMID: 41799409](https://pubmed.ncbi.nlm.nih.gov/41799409/). *Respir Med Case Rep*. [Case Report / Case Series]
Fernández Pérez ER (2026). [PMID: 42127984](https://pubmed.ncbi.nlm.nih.gov/42127984/). *Ann Am Thorac Soc*. [Diagnostic / Biomarker]
Tsubouchi K (2026). [PMID: 41704708](https://pubmed.ncbi.nlm.nih.gov/41704708/). *ERJ Open Res*. [Clinical Trial Publication]
AI-curated news mentioning fibrotic hypersensitivity pneumonitis
Updated Sep 15, 2026
A recent case report highlights the misdiagnosis of hot tub lung as hypersensitivity pneumonitis, revealing a mycobacterial cause. This underscores the need for accurate diagnosis in similar respiratory conditions.
A case series highlights acute respiratory failure as a rare presentation of non-fibrotic hypersensitivity pneumonitis. This discovery may prompt further research into the clinical manifestations and management of this condition.
A new study explores cyst-predominant nonfibrotic hypersensitivity pneumonitis, which can mimic Birt-Hogg-Dubé syndrome. This research may enhance diagnostic accuracy for these conditions.